| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.07e-04 | 446 | 84 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK20 STK3 PHKA1 ATR POLE TBK1 PANK4 CRPPA TNKS HUNK WNK4 AURKB STK25 | 1.41e-04 | 938 | 84 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.45e-04 | 363 | 84 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 7.70e-04 | 10 | 84 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 7.72e-04 | 709 | 84 | 10 | GO:0016773 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 8.40e-04 | 44 | 84 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | protein kinase activity | 9.33e-04 | 600 | 84 | 9 | GO:0004672 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 9.78e-04 | 180 | 84 | 5 | GO:0004866 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomerase | 1.30e-05 | 36 | 83 | 4 | GO:0032212 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomere lengthening | 1.80e-05 | 39 | 83 | 4 | GO:1904358 | |
| Domain | RMMBL | 5.84e-05 | 3 | 83 | 2 | IPR011108 | |
| Domain | RMMBL | 5.84e-05 | 3 | 83 | 2 | PF07521 | |
| Domain | Beta-Casp | 1.16e-04 | 4 | 83 | 2 | PF10996 | |
| Domain | Beta_Casp | 1.16e-04 | 4 | 83 | 2 | IPR022712 | |
| Domain | Beta-Casp | 1.16e-04 | 4 | 83 | 2 | SM01027 | |
| Domain | Anaphylatoxin_comp_syst | 1.93e-04 | 5 | 83 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.93e-04 | 5 | 83 | 2 | IPR001840 | |
| Domain | Serpin_CS | 3.82e-04 | 32 | 83 | 3 | IPR023795 | |
| Domain | ANATO | 4.04e-04 | 7 | 83 | 2 | SM00104 | |
| Domain | ANATO | 4.04e-04 | 7 | 83 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 4.04e-04 | 7 | 83 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 4.04e-04 | 7 | 83 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 4.04e-04 | 7 | 83 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 5.37e-04 | 8 | 83 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 5.37e-04 | 8 | 83 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 5.37e-04 | 8 | 83 | 2 | IPR019742 | |
| Domain | Serpin_dom | 5.44e-04 | 36 | 83 | 3 | IPR023796 | |
| Domain | SERPIN | 5.90e-04 | 37 | 83 | 3 | SM00093 | |
| Domain | SERPIN | 5.90e-04 | 37 | 83 | 3 | PS00284 | |
| Domain | Serpin | 6.38e-04 | 38 | 83 | 3 | PF00079 | |
| Domain | Serpin_fam | 6.89e-04 | 39 | 83 | 3 | IPR000215 | |
| Domain | A2M_N | 8.58e-04 | 10 | 83 | 2 | PF01835 | |
| Domain | A2M_N | 8.58e-04 | 10 | 83 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 8.58e-04 | 10 | 83 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 8.58e-04 | 10 | 83 | 2 | PS00477 | |
| Domain | A2M | 8.58e-04 | 10 | 83 | 2 | PF00207 | |
| Domain | A2M_N_2 | 8.58e-04 | 10 | 83 | 2 | IPR011625 | |
| Domain | A2M_comp | 8.58e-04 | 10 | 83 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 8.58e-04 | 10 | 83 | 2 | PF07703 | |
| Domain | A2M_recep | 8.58e-04 | 10 | 83 | 2 | PF07677 | |
| Domain | A2M_comp | 8.58e-04 | 10 | 83 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 8.58e-04 | 10 | 83 | 2 | IPR001599 | |
| Domain | Ser/Thr_kinase_AS | 1.05e-03 | 357 | 83 | 7 | IPR008271 | |
| Domain | S_TKc | 1.09e-03 | 359 | 83 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.14e-03 | 362 | 83 | 7 | PS00108 | |
| Domain | Lactamase_B | 1.47e-03 | 13 | 83 | 2 | PF00753 | |
| Domain | Pkinase | 1.53e-03 | 381 | 83 | 7 | PF00069 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.72e-03 | 14 | 83 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.72e-03 | 14 | 83 | 2 | IPR024743 | |
| Domain | Zip | 1.72e-03 | 14 | 83 | 2 | PF02535 | |
| Domain | Dynein_heavy_dom-2 | 1.72e-03 | 14 | 83 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.72e-03 | 14 | 83 | 2 | PF08393 | |
| Domain | MT | 1.72e-03 | 14 | 83 | 2 | PF12777 | |
| Domain | AAA_8 | 1.72e-03 | 14 | 83 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.72e-03 | 14 | 83 | 2 | IPR011704 | |
| Domain | ZIP | 1.72e-03 | 14 | 83 | 2 | IPR003689 | |
| Domain | AAA_5 | 1.72e-03 | 14 | 83 | 2 | PF07728 | |
| Domain | DHC_fam | 1.97e-03 | 15 | 83 | 2 | IPR026983 | |
| Domain | Lactamase_B | 1.97e-03 | 15 | 83 | 2 | SM00849 | |
| Domain | Dynein_heavy_dom | 1.97e-03 | 15 | 83 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.97e-03 | 15 | 83 | 2 | PF03028 | |
| Domain | C345C | 2.54e-03 | 17 | 83 | 2 | SM00643 | |
| Domain | Kinase-like_dom | 2.80e-03 | 542 | 83 | 8 | IPR011009 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.85e-03 | 18 | 83 | 2 | IPR008930 | |
| Domain | NTR | 3.18e-03 | 19 | 83 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 3.18e-03 | 19 | 83 | 2 | IPR018933 | |
| Domain | - | 3.52e-03 | 20 | 83 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 3.52e-03 | 20 | 83 | 2 | IPR001279 | |
| Domain | PROTEIN_KINASE_ATP | 4.31e-03 | 459 | 83 | 7 | PS00107 | |
| Pathway | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | 4.48e-05 | 15 | 67 | 3 | MM14782 | |
| Pathway | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | 1.10e-04 | 20 | 67 | 3 | M538 | |
| Pubmed | STK3 TFB1M POLE TBK1 UGGT1 PANK4 HIP1R ANKRD28 TUBGCP5 DIS3 AURKB STK25 | 2.54e-08 | 606 | 84 | 12 | 36538041 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FASN ERCC6 TFB1M SERPINB4 SERPINB12 POLE SHCBP1 RPP30 INTS11 HIP1R CCT8 GEMIN5 ANKRD28 DHX33 CPSF3 DIS3 | 1.33e-07 | 1353 | 84 | 16 | 29467282 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TACO1 FASN POLE RPP30 INTS11 CCT8 EIF3C DHX33 DNAH8 MRPL11 AURKB | 1.05e-06 | 704 | 84 | 11 | 29955894 |
| Pubmed | 3.87e-06 | 650 | 84 | 10 | 38777146 | ||
| Pubmed | 5.05e-06 | 102 | 84 | 5 | 31722399 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SERPINB4 TBK1 SHCBP1 APBA2 ANKRD28 TNKS EIF3C DHX33 USP48 DIS3 SLC39A7 STK25 | 5.30e-06 | 1005 | 84 | 12 | 19615732 |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 5.76e-06 | 2 | 84 | 2 | 16565498 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 5.76e-06 | 2 | 84 | 2 | 7373044 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 5.76e-06 | 2 | 84 | 2 | 3696167 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35350380 | ||
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 5.76e-06 | 2 | 84 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 5.76e-06 | 2 | 84 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 5.76e-06 | 2 | 84 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 5.76e-06 | 2 | 84 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 5.76e-06 | 2 | 84 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 5.76e-06 | 2 | 84 | 2 | 15787745 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12207352 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 30026462 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 5.76e-06 | 2 | 84 | 2 | 27758680 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 5.76e-06 | 2 | 84 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 5.76e-06 | 2 | 84 | 2 | 20506482 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12480675 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 5.76e-06 | 2 | 84 | 2 | 23749435 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 5.76e-06 | 2 | 84 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 5.76e-06 | 2 | 84 | 2 | 3037333 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11726230 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 5.76e-06 | 2 | 84 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 5.76e-06 | 2 | 84 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 5.76e-06 | 2 | 84 | 2 | 2997024 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 5.76e-06 | 2 | 84 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 5.76e-06 | 2 | 84 | 2 | 8428773 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21857912 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24638111 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 5.76e-06 | 2 | 84 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 5.76e-06 | 2 | 84 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 5.76e-06 | 2 | 84 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 5.76e-06 | 2 | 84 | 2 | 3167981 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 7545960 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 30041577 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2572548 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 5.76e-06 | 2 | 84 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 5.76e-06 | 2 | 84 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 5.76e-06 | 2 | 84 | 2 | 18360261 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 5.76e-06 | 2 | 84 | 2 | 18091514 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 5.76e-06 | 2 | 84 | 2 | 26814963 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 5.76e-06 | 2 | 84 | 2 | 25339671 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17728371 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6149580 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6149581 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12115608 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 3542363 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2387317 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 8132550 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2395880 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26814708 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6192448 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6167582 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 5.76e-06 | 2 | 84 | 2 | 1438267 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 7365238 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19150565 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 7391573 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17506029 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17971360 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23715124 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 3464002 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 5.76e-06 | 2 | 84 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 5.76e-06 | 2 | 84 | 2 | 17971229 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6881182 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 5.76e-06 | 2 | 84 | 2 | 3944109 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 5.76e-06 | 2 | 84 | 2 | 17921792 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 5.76e-06 | 2 | 84 | 2 | 6978711 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35898513 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33353966 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 3008092 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 28873507 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 5.76e-06 | 2 | 84 | 2 | 2900855 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 5.76e-06 | 2 | 84 | 2 | 6832377 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 36822327 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 3794341 | ||
| Pubmed | Complement and c4 null alleles in severe chronic adult periodontitis. | 5.76e-06 | 2 | 84 | 2 | 17257223 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2272665 | ||
| Interaction | CLEC16A interactions | STK3 TFB1M POLE TBK1 UGGT1 PANK4 HIP1R ANKRD28 TUBGCP5 DIS3 AURKB STK25 | 1.12e-05 | 629 | 84 | 12 | int:CLEC16A |
| Interaction | TAX1BP1 interactions | 1.26e-05 | 342 | 84 | 9 | int:TAX1BP1 | |
| Cytoband | 12q24 | 1.32e-05 | 25 | 84 | 3 | 12q24 | |
| GeneFamily | Serpin peptidase inhibitors | 1.72e-04 | 37 | 53 | 3 | 739 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.00e-04 | 9 | 53 | 2 | 1234 | |
| GeneFamily | Dyneins, axonemal | 1.11e-03 | 17 | 53 | 2 | 536 | |
| GeneFamily | Complement system|Sushi domain containing | 4.98e-03 | 36 | 53 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 5.26e-03 | 37 | 53 | 2 | 454 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 7.12e-03 | 134 | 53 | 3 | 861 | |
| GeneFamily | PDZ domain containing | 1.00e-02 | 152 | 53 | 3 | 1220 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-06 | 177 | 84 | 6 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.94e-06 | 196 | 84 | 6 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 197 | 84 | 6 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.88e-06 | 140 | 84 | 5 | 7b359bfbd404ab06d799048252f4985d85852048 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Eosinophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.92e-05 | 173 | 84 | 5 | a85cead231e03945fabbc7762540ad21fe4299df | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 175 | 84 | 5 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 181 | 84 | 5 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 181 | 84 | 5 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 183 | 84 | 5 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 185 | 84 | 5 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.85e-05 | 188 | 84 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 2.93e-05 | 189 | 84 | 5 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 3.08e-05 | 191 | 84 | 5 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 84 | 5 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.23e-05 | 193 | 84 | 5 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.32e-05 | 194 | 84 | 5 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 195 | 84 | 5 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.40e-05 | 195 | 84 | 5 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.40e-05 | 195 | 84 | 5 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | distal-Epithelial-Proximal_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-05 | 196 | 84 | 5 | c102b28d5d1d90b9f7024cb51114276354be26a5 | |
| ToppCell | distal-Epithelial-Proximal_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-05 | 196 | 84 | 5 | a543d4623096cb3f9170dbf7af52381e77aa435e | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.48e-05 | 196 | 84 | 5 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.48e-05 | 196 | 84 | 5 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-05 | 197 | 84 | 5 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 197 | 84 | 5 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 197 | 84 | 5 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.65e-05 | 198 | 84 | 5 | c79c1738560d78b63dbed5f2f9621dbc1c2363cb | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.65e-05 | 198 | 84 | 5 | 1d1c80569f1e307285ba0ebaf5c72e0b5b538864 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.65e-05 | 198 | 84 | 5 | f37578f156e8aed2ce30cfa837ae04dd18de05d0 | |
| ToppCell | COVID-19_Severe-Neu_4|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 3.65e-05 | 198 | 84 | 5 | bfdddddef9f3f0eb6af013873dec4e06b7c78c58 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 3.65e-05 | 198 | 84 | 5 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | COVID-19_Severe-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 3.74e-05 | 199 | 84 | 5 | 0e327479bbda5a16643cf317d293a2918d619f87 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.74e-05 | 199 | 84 | 5 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-CD14_monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-05 | 199 | 84 | 5 | 50a30d5ee99e51743a0dd60144fc341ff68da9af | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.83e-05 | 200 | 84 | 5 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.83e-05 | 200 | 84 | 5 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 151 | 84 | 4 | 2dc132895609e4efe17954e31f53d9c1ccf256ef | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 151 | 84 | 4 | 22afd8201eff8471da3456be065f2790de5e4bfe | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.01e-04 | 153 | 84 | 4 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 156 | 84 | 4 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 156 | 84 | 4 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-04 | 160 | 84 | 4 | 50d4f867d021abcfeb49e6812bcfd5bb57466a31 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-04 | 160 | 84 | 4 | 0f15f895f11dcabb73df79b26bfc4947f38435a7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-04 | 160 | 84 | 4 | 7d004bfe42707605b3851cb2319126acda4d4802 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 168 | 84 | 4 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 169 | 84 | 4 | 42c31fe94e34f54dbbb5d8b33cedb55badd6232c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 170 | 84 | 4 | ece7c20e89c190a7ec68032b6c2efeb458c43f9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-04 | 171 | 84 | 4 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-04 | 173 | 84 | 4 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 173 | 84 | 4 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | a693772987f1baee533dd0bd285a3c7b5619a73b | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.28e-04 | 174 | 84 | 4 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 174 | 84 | 4 | ce9bdd02dc8eb45ba9c1481619c0089b465e6442 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 175 | 84 | 4 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.35e-04 | 175 | 84 | 4 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 3.57e-04 | 178 | 84 | 4 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 3.57e-04 | 178 | 84 | 4 | 67aa17b17da3121c199af45e747c23e2626a9bb2 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | 6bad4439a1692332f70135ff446a1048fa4c399d | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | 3f6feb4ed7779cf5684f52939350b41d7718c3c6 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.65e-04 | 179 | 84 | 4 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-04 | 179 | 84 | 4 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 181 | 84 | 4 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.80e-04 | 181 | 84 | 4 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 182 | 84 | 4 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.88e-04 | 182 | 84 | 4 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | (00)_Basal-(0)_uninjured|(00)_Basal / shred by cell type and Timepoint | 3.88e-04 | 182 | 84 | 4 | c02c9cab4389d80f318f4bb8d703c1e719672624 | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.96e-04 | 183 | 84 | 4 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-04 | 184 | 84 | 4 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-04 | 184 | 84 | 4 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-04 | 184 | 84 | 4 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.05e-04 | 184 | 84 | 4 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-04 | 184 | 84 | 4 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.13e-04 | 185 | 84 | 4 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | normal-na-Myeloid-conventional_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.13e-04 | 185 | 84 | 4 | 67e881a89a491665b8c612fff084c202c0c79235 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 4.13e-04 | 185 | 84 | 4 | 912d8efdc37820dbb07736221a98af929e5a7c97 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 4.22e-04 | 186 | 84 | 4 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 4.22e-04 | 186 | 84 | 4 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.30e-04 | 187 | 84 | 4 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-04 | 187 | 84 | 4 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue | 4.30e-04 | 187 | 84 | 4 | 265c690c2921fd201361a0ec8bc4d2a996fbcaf4 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-04 | 187 | 84 | 4 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-04 | 187 | 84 | 4 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-04 | 187 | 84 | 4 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 4.39e-04 | 188 | 84 | 4 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-04 | 189 | 84 | 4 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 4.48e-04 | 189 | 84 | 4 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 7.59e-05 | 5 | 82 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Frontotemporal Lobar Degeneration | 1.59e-04 | 7 | 82 | 2 | C0751072 | |
| Disease | Frontotemporal Dementia With Motor Neuron Disease | 2.11e-04 | 8 | 82 | 2 | C3888102 | |
| Disease | endometrial cancer (implicated_via_orthology) | 2.11e-04 | 8 | 82 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | 2-hydroxyphenylacetate measurement | 2.11e-04 | 8 | 82 | 2 | EFO_0800131 | |
| Disease | alpha wave measurement, electroencephalogram measurement | 3.38e-04 | 10 | 82 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | nervous system disease (implicated_via_orthology) | 4.94e-04 | 12 | 82 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Agammaglobulinemia | 4.94e-04 | 12 | 82 | 2 | C0001768 | |
| Disease | cathepsin L1 measurement | 8.93e-04 | 16 | 82 | 2 | EFO_0010619 | |
| Disease | Benign neoplasm of stomach | 1.01e-03 | 17 | 82 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.01e-03 | 17 | 82 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.01e-03 | 17 | 82 | 2 | C0154060 | |
| Disease | Malignant neoplasm of endometrium | 1.13e-03 | 18 | 82 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 1.13e-03 | 18 | 82 | 2 | C0346191 | |
| Disease | lung cancer (is_implicated_in) | 1.16e-03 | 74 | 82 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | electroencephalogram measurement | 1.16e-03 | 74 | 82 | 3 | EFO_0004357 | |
| Disease | urinary microalbumin measurement | 1.40e-03 | 20 | 82 | 2 | EFO_0010967 | |
| Disease | Stomach Neoplasms | 1.45e-03 | 297 | 82 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.51e-03 | 300 | 82 | 5 | C0024623 | |
| Disease | Stomach Carcinoma | 1.55e-03 | 21 | 82 | 2 | C0699791 | |
| Disease | neuroblastoma, cutaneous melanoma | 2.75e-03 | 28 | 82 | 2 | EFO_0000389, EFO_0000621 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIVFKAKHVETGEIV | 16 | Q8IZL9 | |
| AKHVETGEIVALKKV | 21 | Q8IZL9 | |
| AVSKVLQIEKEGAIH | 926 | P0C0L5 | |
| ETINFHEVKEVAGIK | 136 | Q9UKF6 | |
| IEVVKLLVSHGAEVT | 186 | O15084 | |
| FIFAHVKGIEKEVNV | 106 | Q8TF65 | |
| LEKHKGEILGVVVVE | 571 | Q99767 | |
| LFQIVSKHLKEVTEV | 266 | Q96M95 | |
| ALGQEHDITLFVKVK | 446 | Q96NY7 | |
| KLGIVNVDEAVLHFK | 616 | Q6ZUJ8 | |
| VLEKLFKKSVGVHSV | 1251 | Q03468 | |
| HKVKVVVFDKTGTIT | 1036 | Q04656 | |
| VFHGVDSKAVFLLKI | 96 | P34972 | |
| FVEEGVLLKVVTAAK | 161 | A4D126 | |
| KVKKFRTHVEEGDIV | 246 | Q8IWT6 | |
| VAEVVTFERGHKIII | 4856 | Q8NEZ4 | |
| FLKKVHETVERGGKV | 221 | Q5TA45 | |
| EIHSIGSIIAVEKIV | 1141 | P46020 | |
| VIDYVLHGKEEIKVI | 316 | P35913 | |
| NFIKEGVLVEHVKNV | 51 | Q9Y6X5 | |
| KFDRVKFETLITIHV | 1746 | Q96JB1 | |
| FLKIVELFKEVVVHL | 556 | Q5GLZ8 | |
| EDALAKVTKIILAFH | 466 | Q96MW5 | |
| IEKTIEGIYEKFVIH | 61 | Q96RT8 | |
| SFHTVEDLVKVRKEI | 156 | Q07864 | |
| KEEFTTLQKIVLHEV | 376 | Q96JA3 | |
| AKITVVDALHEIPVK | 261 | Q16270 | |
| DFIKDHLVNTETKVI | 106 | Q9NVE7 | |
| GLFGKSTVIIHVIDV | 326 | Q9Y5F2 | |
| VHTKVKGIAEVKEEI | 61 | Q99572 | |
| VENGVKKLVHSVFDT | 76 | Q99572 | |
| GTEITHAVVIKKLNE | 321 | Q99613 | |
| HKGQIEVESETIFKL | 166 | Q9Y2L6 | |
| HIESISKVAEVAGKE | 1141 | Q9P2D7 | |
| GEVVNEKAKTHVLDI | 2581 | Q13535 | |
| DKVVLHTGKYEELIV | 891 | O75146 | |
| GKIAVEVHKSIVNEL | 506 | Q96ST8 | |
| HVLTGEKVAIKVIDK | 81 | P57058 | |
| LIEKVHIGVKGFVKD | 376 | O75976 | |
| IHTDVLFGVVKAAQK | 201 | Q9H6R0 | |
| LADKFIHAGVKVVFS | 231 | Q9BRF8 | |
| KKVVVHLETILGASV | 331 | Q6GMR7 | |
| GFLNVLEVLKHEVKI | 311 | Q9Y2T3 | |
| RDIFISKIVHKSFVE | 311 | P30740 | |
| GKHIGKVVVQVLAEE | 1846 | P49327 | |
| ALEFVVSKVEGEIKH | 716 | D6RIA3 | |
| FVHAKKVSFTVEVLL | 371 | Q9UDX4 | |
| DVKFFVLSEKGVIIV | 81 | Q96LT7 | |
| AVSKVLQIEKEGAIH | 926 | P0C0L4 | |
| LVHRVAIVSEKGEVK | 866 | Q12756 | |
| KEVAGLVTLKHVYEI | 106 | Q9Y3B7 | |
| SVVAINHIVDFKEKK | 31 | P78346 | |
| EVVSHVIKQGKIVFV | 56 | P32754 | |
| DAEKVHFILVEKVTT | 206 | Q9NUP7 | |
| HFILVEKVTTRFKVD | 211 | Q9NUP7 | |
| IISKDTTAKEVVFHA | 766 | Q8TEU7 | |
| HSFDKKGVIVVEVED | 181 | Q9BSH4 | |
| KGESQVFKKAVVLHV | 121 | Q86YT9 | |
| VKVGLSDAFVVVHRI | 276 | Q6UX71 | |
| KVVSLFVGVAVHETL | 196 | Q9BRY0 | |
| RIVHGDVLTFKVEKA | 106 | Q8WVM0 | |
| IKFAIKDGIVTADII | 2526 | Q9UKZ4 | |
| IKISGIKFVQHDAVE | 431 | Q8NEM2 | |
| IEDTVFHVFDKVKVK | 896 | Q9Y2L1 | |
| KGIDNHTKEVVAIKI | 36 | O00506 | |
| LSKIIHKTFVEVDEN | 341 | Q96P63 | |
| AKAIVVHGAELKDIQ | 666 | Q13733 | |
| TIVDKVKEVLFQHSG | 186 | Q96CD2 | |
| KVLFKSQIEKEGVEH | 106 | Q96GD4 | |
| VFKAIHKESGQVVAI | 41 | Q13188 | |
| SKHELVFVDTKGVVK | 176 | O95625 | |
| AVKASFGIVTKHEVE | 111 | Q0ZLH3 | |
| ENFSVAGKIHTVKIE | 336 | Q9Y6Q2 | |
| GIVAFLVVEKFVRHV | 226 | Q92504 | |
| KTVEIKAIGHVIEEG | 101 | Q9UH03 | |
| LHEAAIKGKIDVCIV | 286 | O95271 | |
| LIIVEGKEFSAHKVV | 91 | Q5SVQ8 | |
| VVIIDISKKGEVIHR | 176 | Q8TEQ6 | |
| SKVLHKAFVEVTEEG | 326 | P48594 | |
| IRTALFEKVLDKIVH | 131 | Q2NKQ1 | |
| ILKKLVIHFGVVDFL | 386 | Q9H330 | |
| VVFKHEKEDGAISTI | 361 | P50990 | |
| FVVDHVIKITRIEVG | 811 | Q86UV5 | |
| SFHKVKIPEVKEIIE | 396 | Q96J92 | |
| GEKVKVEHVVSVLEK | 581 | Q9NYU2 | |
| VVEGKVFKAHKNVLL | 36 | Q86UZ6 | |
| ETVHKKTEVVITLDF | 456 | Q9UHD2 | |
| EFSALVAIKEKIHIL | 106 | Q9UFV3 |